Background -Headache may be due to either a primary or secondary disorder, and neuroimaging assessments can play an important role when differentiating between these types of headache. Although many studies have reported no significant differences between primary headache patients and the general population in terms of abnormal neuroimaging findings, others have shown that neuroimaging may be employed to rule out secondary causes of headache that could impact morbidity and mortality. This issue remains under debate. Thus, the present study compared the neuroimaging findings of headache patients and healthy controls.
Headache is a common complaint within the general community. The worldwide prevalence of active headache symptoms is estimated to be 46%, 1 and the estimated 1-year prevalence of primary headache disorders in China is 23.8%. 2 A systematic analysis by the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) reports that migraine has become the second largest cause of disability. 3 Early diagnosis and treatment, reducing unnecessary auxiliary examinations are all important means to lift the burden of headaches. What causes the burden of neuroimaging for primary headache patients? As we know, headache may be caused by primary or secondary disorders. Primary headaches are defined as headaches not caused by a specific medical condition and include migraine, tension-type headache (TTH), cluster headache, and other primary headache disorders. Secondary headaches are defined as headaches that are caused by a specific medical condition and include stroke, brain tumors, cerebral hemorrhage, and subarachnoid hemorrhage, among others. Neuroimaging can play an important role in differentiating between primary and secondary headache disorders. In order to avoid above serious consequences, many primary headache patients have been assessed with neuroimaging, even more than once.
Computerized clinical decision support systems (CDSS) have been independently designed by the Headache Center of the Chinese People's Liberation Army General Hospital, which used International Classification of Headache Disorders (ICHD) diagnostic criteria as its diagnostic standard. According to the clinical symptoms input, CDSS could show us the primary diagnostic results by connecting the clinical symptoms with the diagnostic standard mentioned above. CDSS is an interactive decision support system (DSS) computer software, which is designed to assist clinicians and other health professionals with decision making tasks. We proposed a method of constructing a computerized clinical guideline model and medical knowledge base. Firstly, headache specialists summarized diagnostic knowledge in text-based guideline (ICHD), and then translated it into a thought process of headache diagnosis, which was expressed in the form of a flowchart. Secondly, according to these flow charts, knowledge engineers established the computerized clinical guideline representation model by referencing the modeling method of SAGE, and expressed it in the form of SAGE activity graph. Defining the domain ontology, setting up some necessary clinical data modules, and summarizing and defining the logical comparison expression in headache diagnosis were required in this step. Finally, the computerized clinical guideline representation module of headache diagnosis was translated into rules that can be executed in the inference engine of CDSS. A "rule generator" program was developed to map 3 elements (Decision, Action, and Context) of the computerized clinical guideline representation module to the 2 parts of the rule (left-hand side and right-hand side) automatically in order to build a knowledge base. Mapping method: Triggering events in Contexts and conditions in Decisions were mapped to LHS to choose scenarios and make decisions and Recommendations in action elements via the RHS while the rules were fired. 4 The data of the primary headache patients who were diagnosed by CDSS and re-diagnosed by a specialist were permanently preserved in CDSS. However, the accuracy of the diagnosis of primary headaches had been improved, but many doctors still worry about leaving secondary headaches out. So, this study aims to further verify that primary headache patients do not need neuroimaging, and thus reduce their burden.
METHODS
From June 2015 to June 2016, in the Headache Center of Chinese People's Liberation Army General Hospital, 1070 primary headache patients were diagnosed by CDSS and re-diagnosed by specialists (RFW, HS, RA). If the headache diagnosis was different between CDSS and the headache specialists, the chief headache specialists (SYY, RZL, ZD) rendered the final diagnosis of headache. All patients were recruited consecutively in this study (Table 1) . Furthermore, all patients were examined by one of the staff neurologists and had a normal neurological examination. With regard to other secondary headaches, we looked for "red flags," such as "headache occurred in patients aged more than 50 years old," "headache that is the most painful ever experienced," "headache with positive neurologic signs," "sudden onset headache," and so on to exclude factors such as tumor, stroke, and infection prior to the diagnosis of primary headaches. [4] [5] [6] The 129 patients with "red flags" shown in the CDSS were excluded from this study. Additionally, 1070 healthy controls without neurological symptoms including headache and positive neurological signs were observed by neurologists in the Health Examination Center of the Chinese People's Liberation Army General Hospital between January 2016 and June 2016. The healthy controls were recruited and gender-and age-matched with the primary headache patients and enrolled consecutively ( Table 2 ). All participants in this study were assessed with either computed tomography (CT) or magnetic resonance imaging (MRI) scans. The choice to use either a CT or MRI scan was made on an individual basis in consideration of factors such as cooperation, contraindications for MRI, and waiting lists for the procedures. The MRI scans were performed with 3.0-T imagers (GE DISCOVERY MR), and the imaging protocol included standard sagittal and axial T1-weighted and axial T2-weighted imaging scans. The CT scans (GE LIGHT SPEED CT) were performed with high-resolution scanners.
The radiologists who performed the CT and MRI scans did not have access to the clinical histories of the patients but were aware of their age, sex, and presence of allergies to contrast. The neuroimaging results were classified as significant abnormalities, non-significant abnormalities, or normal. Significant abnormalities included neoplastic disease, hydrocephalus, vascular malformations (aneurysms, arteriovenous malformations, dural fistula, and/or cavernous angiomas), Chiari malformations, intracranial hemorrhages, and acute cerebral infarcts. 7 Furthermore, many studies have reported that the incidence rate of white matter lesions is higher in migraine patients than healthy controls. [8] [9] [10] In the present study, white matter lesions were not taken into account because this did not affect the diagnoses of primary headaches.
RESULTS
The present study evaluated 1070 consecutive patients (345 male, 40.05 ± 12.30 years) and 1070 healthy controls (345 male, 40.18 ± 12.46). The age of 2 groups did not significantly differ (P > .05, Table 1 ). The types of headache exhibited by the participants included migraine (665, 62.15%), TTH (338, 31.59%), trigeminal autonomic cephalalgias (TACs; 51, 4.77%), and other primary headache disorders (16, 1.50%; Table 2 ).
Of the 1070 patients, 382 underwent CT scans and 688 underwent MRI scans, and the same as the 1070 healthy controls (Table 3 ). All the significant abnormalities were found using MRI. Among all patients with primary headaches diagnosed by CDSS and re-diagnosed by a specialist, neuroimaging detected significant abnormalities in 4 primary headache patients (0.58%), which included hydrocephalus (n = 2) and tumors on the throat and nose (n = 2). The rate of neuroimaging abnormality of migraine without aura was 0.46%, retinal migraine was 6.25%, and probable migraine was 1.01%, whereas the rate of chronic TTH was 1.56% (Table 4) .
Neuroimaging detected significant abnormalities in 5 healthy controls (0.73%), including cerebral infarction (n = 2), acoustic schwannoma (n = 1), and cavernous angioma (n = 2). Chi-square tests implemented using SPSS 14.0 revealed that the rates of significant abnormalities in the patients and healthy controls did not significantly differ (P = .738, P > .05). Non-significant abnormalities in this study included micro-arachnoid cysts, mild cerebral atrophy, symmetric pallidum calcification, nasosinusitis, pituitary microadenoma, and Rathke cleft cyst, which were found using MRI or CT. 
DISCUSSION
The present neuroimaging findings showed that the rate of significant abnormalities in primary headache patients in this study was 0.58% and that of healthy controls was 0.73%. These 2 rates did not significantly differ, which is similar to the findings of other studies that assessed healthy volunteers. [11] [12] [13] These findings suggest primary headache patients did not get additional benefits from neuroimaging. It was unnecessary for patients with primary headaches to perform neuroimaging examination. Considering relatively high frequency of significant abnormalities among retinal migraine patients (6.25%), it seems to be reasonable to consider neuroimaging for retinal migraine. But due to the small number of patients with retinal migraine in this study, the higher significant abnormalities rate was not significant to the clinical. The significant abnormality of the retinal migraine patient was hydrocephalus, and as we know, it was not the only reason for the headache. For certain, the pathogenesis of retinal migraine is not clear, and the diagnostic criteria in ICHD versions have changed. When we found retinal migraine, we often suggested that the patient have a thorough examination, including improved neuroimaging, to find out the cause of the disease, and this would not lead a financial burden to patients. The same is true for other primary headache patients with lower incidence.
The rate of significant abnormalities in primary headache patients was not significantly different than with that of healthy controls. This conclusion is similar to many other studies. For example, a study by Sempere et al utilized MRI or CT brain scans in 1876 consecutive patients to refer them to a neurology department for headache. The rate of significant lesions in the patients with a normal neurological examination was 0.9%. 7 Another Japanese study by Tsushima et al retrospectively reviewed the MRI brain scans of 306 patients who had normal neurological exams but episodic and chronic headaches for >1 month, and reported that there were only 2 patients exhibiting a significant abnormality, one had a subdural hemorrhage, and the other had a pituitary adenoma.
14 These significant abnormalities in the neuroimaging findings were also observed in the general population. For example, a study by Vernooij et al analyzed the data of 2000 individuals from the population-based Rotterdam Study who underwent high-resolution structural brain MRI (1.5 T) scans using a standardized protocol. Asymptomatic brain infarcts were present in 145 individuals (7.2%), and the most frequent abnormalities other than infarcts were Of the participants who required an urgent referral, 2 (0.2%) had confirmed primary brain tumors. 13 In conclusion, the occurrence of significant abnormalities on the neuroimaging findings of the general population was not any lower than that observed for primary headache patients. A variety of factors contribute to the overuse of neuroimaging in headache patients. On the one hand, patients with headache are anxious about the possibility that they have a brain tumor or aneurysm. For example, one study conducted in a London headache clinic assessed 150 patients with chronic daily headache who were randomly selected to undergo MRI scans and then followed for 1 year. The scanned patients were worried about being diagnosed with a serious cause for their headache at 1 year. 15 On the other hand, secondary causes of headache, such as tumors and strokes that could impact patient morbidity and mortality, may induce anxiety in clinicians. Some studies had suggested that, even though most headaches were a due to a primary headache disorder with a benign course, neuroimaging could be an important aspect of a diagnostic evaluation because these tests could exclude the presence of a secondary cause of headache that might produce fatal results or severe neurological morbidity. 16 The proportion of patients with headache and intracranial lesions was relatively small, but neither neurological examinations nor the features of a clinical history would allow for the exclusion of these abnormalities. Moreover, neuroimaging might reassure patients and improve their quality of life. 7, 15, 17 In China, the tense relationships and lower levels of trust between physicians and patients were another important cause. 18, 19 Finally, we would like to restate the limitations of the present findings. First, the healthy controls in our research observed by themselves that they had no headache history. But we did not record or inquire about atypical headache conditions during the time we recruited the healthy controls for the study. Second, there was a small number of TACs and other primary headaches such as retinal migraine, primary cough headache, and paroxysmal hemicranias. Third, because of reducing to perform neuroimaging examination for headache patients, the misdiagnosis rate and relevant indirect cost such as a cost for delayed diagnosis including additional disability and death would be improved. There was not further consideration in this study. Fourth, whether or not these primary headache patients would get additional benefits from the contrast MRI and MRA was not considered in this study.
CONCLUSIONS
The present study found that the performance of neuroimaging for primary headache patients did not produce any additional gains compared with those found for the general population. It was unnecessary for patients with primary headaches to perform neuroimaging examination.
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